Effect of High-Flow Oxygen vs Standard Oxygen Therapy on Mortality in Respiratory Failure Due to COVID-19

This randomized clinical trial compares the efficacy of high-flow nasal cannula oxygen vs standard oxygen therapy in reducing the rate of mortality at day 28 in patients with respiratory failure due to COVID-19 admitted in intensive care units.

Read the full article here

Related Articles